Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicole Concin

Showing results (91-100 of 132) with videos related to

Pageof 14
Sort By:
BMC Cancer|April 5, 2013
A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer--a study of the OVCAD consortiumDietmar Pils, Dan Tong, Gudrun Hager, et al.
European Journal of Cancer (Oxford, England : 1990)|September 25, 2023
Verification of the prognostic precision of the new 2023 FIGO staging system in endometrial cancer patients - An international pooled analysis of three ESGO accredited centresRichard Schwameis, Francesco Fanfani, Christoph Ebner, et al.
Frontiers in Oncology|January 5, 2023
Gender-related differences in career development among gynecologic oncology surgeons in Europe. European Network of Young Gynecologic Oncologists' Survey based dataTanja Nikolova, Michaela Bossart, Joanna Kacperczyk-Bartnik, et al.
International Journal of Cancer|April 27, 2024
Gene expression markers in peripheral blood and outcome in patients with platinum-resistant ovarian cancer: A study of the European GANNET53 consortiumEva Obermayr, Thomas Mohr, Eva Schuster, et al.
International Journal of Cancer|May 6, 2024
Loss of copy numbers of retrotransposons (HERVK) on chromosome 7p11.2 impacts EGFR (Epidermal Growth Factor Receptor)-induced phenotypes for platinum sensitivity and long-term survival in ovarian cancer-A study from the OVCAD consortiumGesa Fromhage, Eva Obermayr, Natalia Bednarz-Knoll, et al.
European Journal of Cancer (Oxford, England : 1990)|November 9, 2024
FIGO 2023 staging for endometrial cancer, when, if it is not now?Xavier Matias-Guiu, Sigurd Lax, Maria Rosaria Raspollini, et al.
Cancers|September 9, 2020
Definition and Independent Validation of a Proteomic-Classifier in Ovarian CancerSabine Kasimir-Bauer, Joanna Roder, Eva Obermayr, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 23, 2022
Interviews from the European Society of Gynaecological Oncology 2021 Congress: an IJGC-ENYGO Fellows compilationMartina Aida Angeles, Nicolò Bizzarri, Alexander Shushkevich, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 19, 2021
European Society of Gynaecological Oncology quality indicators for the surgical treatment of endometrial carcinomaNicole Concin, François Planchamp, Nadeem R Abu-Rustum, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 1, 2015
The role of HE4 for prediction of recurrence in epithelial ovarian cancer patients-results from the OVCAD studyMani Nassir, Jun Guan, Hrvoje Luketina, et al.
Pageof 14

Showing results (91-100 of 132) with videos related to

Sort By:
Pageof 14
BMC Cancer|April 5, 2013
A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer--a study of the OVCAD consortiumDietmar Pils, Dan Tong, Gudrun Hager, et al.
European Journal of Cancer (Oxford, England : 1990)|September 25, 2023
Verification of the prognostic precision of the new 2023 FIGO staging system in endometrial cancer patients - An international pooled analysis of three ESGO accredited centresRichard Schwameis, Francesco Fanfani, Christoph Ebner, et al.
Frontiers in Oncology|January 5, 2023
Gender-related differences in career development among gynecologic oncology surgeons in Europe. European Network of Young Gynecologic Oncologists' Survey based dataTanja Nikolova, Michaela Bossart, Joanna Kacperczyk-Bartnik, et al.
International Journal of Cancer|April 27, 2024
Gene expression markers in peripheral blood and outcome in patients with platinum-resistant ovarian cancer: A study of the European GANNET53 consortiumEva Obermayr, Thomas Mohr, Eva Schuster, et al.
International Journal of Cancer|May 6, 2024
Loss of copy numbers of retrotransposons (HERVK) on chromosome 7p11.2 impacts EGFR (Epidermal Growth Factor Receptor)-induced phenotypes for platinum sensitivity and long-term survival in ovarian cancer-A study from the OVCAD consortiumGesa Fromhage, Eva Obermayr, Natalia Bednarz-Knoll, et al.
European Journal of Cancer (Oxford, England : 1990)|November 9, 2024
FIGO 2023 staging for endometrial cancer, when, if it is not now?Xavier Matias-Guiu, Sigurd Lax, Maria Rosaria Raspollini, et al.
Cancers|September 9, 2020
Definition and Independent Validation of a Proteomic-Classifier in Ovarian CancerSabine Kasimir-Bauer, Joanna Roder, Eva Obermayr, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 23, 2022
Interviews from the European Society of Gynaecological Oncology 2021 Congress: an IJGC-ENYGO Fellows compilationMartina Aida Angeles, Nicolò Bizzarri, Alexander Shushkevich, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 19, 2021
European Society of Gynaecological Oncology quality indicators for the surgical treatment of endometrial carcinomaNicole Concin, François Planchamp, Nadeem R Abu-Rustum, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 1, 2015
The role of HE4 for prediction of recurrence in epithelial ovarian cancer patients-results from the OVCAD studyMani Nassir, Jun Guan, Hrvoje Luketina, et al.
Pageof 14